Microbix Biosystems Inc
TSX:MBX

Watchlist Manager
Microbix Biosystems Inc Logo
Microbix Biosystems Inc
TSX:MBX
Watchlist
Price: 0.3 CAD
Market Cap: 42.3m CAD

Microbix Biosystems Inc
Investor Relations

Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The firm manufactures a range of biological materials for the diagnostics industry, notably antigens (Antigen business) used in immunoassays and its quality assessment and proficiency testing controls (QAPs business). The firm operates in two segments: the development, manufacturing, and sales of antigens as materials for the medical diagnostic industry or as quality assessment products (as finished products) and viral transport medium (VTM) and the development and commercialization of products or technologies such as Kinlytic and . The Kinlyti urokinase, which is a biologic thrombolytic drug used to treat blood clots. The firm's catalogue of catalogue covers a range of pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually transmitted and insect-borne diseases. Its QAPs are available in over 30 countries.

Show more
Loading
MBX
S&P TSX Composite Index (Canada)

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Cameron L. Groome
President, CEO & Director
No Bio Available
Mr. James S. Currie
Chief Financial Officer
No Bio Available
Dr. Kenneth Hughes Ph.D.
Chief Operating Officer
No Bio Available
Dr. Mark Luscher Ph.D.
Senior Vice President of Scientific Affairs
No Bio Available
Mr. Philip Casselli
Senior Vice President of Sales, Business Development & Marketing
No Bio Available
Mr. Christopher B. Lobb
Compliance Officer, General Counsel & Secretary
No Bio Available

Contacts

Address
ONTARIO
Mississauga
265 Watline Avenue
Contacts
+19053618910.0
microbix.com